Dynamic Purchasing System for Commonly Used Pharmaceutical Products
Original notice title
Bulgaria – Pharmaceutical products – Динамична система за покупки на обичайно използвани лекарствени продукти за нуждите на МБАЛ „Свети Пантелеймон – Пловдив“ ЕООД
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
60 / 100
Risk factors
EU funding flag is true in structured data but XML notice indicates 'no-eu-funds'. This may affect contract terms or bu...
Stringent licensing requirements (wholesale, narcotics, import permits) may exclude some suppliers.
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Tender facts
- Contracting authority
- МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ "СВ. ПАНТЕЛЕЙМОН - ПЛОВДИВ" ЕООД
- Country
- Bulgaria
- CPV
- 33600000 - Pharmaceutical products
- Deadline
- Jun 15, 2030
- Estimated value
- EUR 3.3M
Overview
Strong opportunityKey Facts
- EUR 3.3M estimated value
- Dynamic Purchasing System (DPS)
- Supplies contract
- 1 lot
- Duration 48 MONTH
- Supply of pharmaceutical products to the hospital
- Products may include those from the Positive Drug List and others
Show full summary
This tender establishes a Dynamic Purchasing System (DPS) for the supply of commonly used pharmaceutical products to the hospital MBAL 'Sveti Panteleymon – Plovdiv' EOOD, including products from the Positive Drug List and others. The DPS has a single lot (LOT-0001) and a duration of 48 months. The procedure is restricted, and the award criterion is the lowest price.
Risks
EU funding flag is true in structured data but XML notice indicates 'no-eu-funds'. This may affect contract terms or bu...
Stringent licensing requirements (wholesale, narcotics, import permits) may exclude some suppliers.
Restricted procedure — pre-qualification required
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Participation is restricted to the second stage of the DPS after initial selection
Administrative
- Electronic submission is required
- Tenders must be submitted via the CAIS EOP platform
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
гр. Пловдив, BGR
Website
Buyer profile
Identifier
115517517
Activity
Health
Lots (1)
LOT-0001
Dynamic Purchasing System for Commonly Used Pharmaceutical Products
Supply of pharmaceutical products, including those listed in Appendix 2 of the Positive Drug List and others not listed, to meet the needs of the hospital's medical units.
EUR 3.3M
Estimated value
Location
Duration
Category
Award Criteria
Deadline
Award details
Оценяването и класирането на офертите на участниците се извършва по критерия „НАЙ-НИСКА ЦЕНА”, съгласно чл. 70, ал. 2, т. 1 от ЗОП.
Value note
Show original TED data
Original lot title
Динамична система за покупки на обичайно използвани лекарствени продукти за нуждите на МБАЛ „Свети Пантелеймон – Пловдив“ ЕООД
Original TED description
В рамките на динамичната система за покупки (ДСП) ще бъдат възлагани обществени поръчки за доставки на обичайно използвани лекарствени продукти за нуждите на МБАЛ „Свети Пантелеймон – Пловдив“ ЕООД, в това число лекарствени продукти, включени в Приложение №2 на Позитивния лекарствен списък, както и лекарствени продукти, които не са включени в ПЛС, като с поръчките се цели се цели да се обезпечат работните нужди на медицински звена, обособени и функциониращи в лечебното заведение.
Procurement Details
- Publication date
- 15 Jun 2026
- Languages
- Bulgarian
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 410285-2026
Documents (1)
Similar tenders
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
60 / 100
Risk factors
EU funding flag is true in structured data but XML notice indicates 'no-eu-funds'. This may affect contract terms or bu...
Stringent licensing requirements (wholesale, narcotics, import permits) may exclude some suppliers.
Restricted procedure — pre-qualification required
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications